CoChat

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants

Open access
Himmerich, Hubertus, Minkwitz, Juliane, Kirkby, Kenneth · 2015 · Endocrine, Metabolic & Immune Disorders-Drug Targets

Abstract

Weight gain and metabolic disturbances are common side effects during psychopharmacological treatment with specific antipsychotics and antidepressants. The antipsychotics clozapine and olanzapine, and antidepressants tricyclics and mirtazapine have a high risk of inducing weight gain. Recently discovered pathophysiological mechanisms include antihistaminergic effects, activation of hypothalamic adenosine monophosphate-activated protein kinase (AMPK), modulation of hormonal signaling of ghrelin and leptin, changes in the production of cytokines such as tumor necrosis factor-alpha (TNF)-alpha and adipokines such as adiponektin, and the impact of genes, in particular the melanocortin 4 receptor (MC4R), serotonin 2C receptor (HTR2C), leptin, neuropeptide Y (NPY) and cannabinoid receptor 1 (CNR1) genes. Metabolic changes associated with weight gain include disturbances of glucose and lipid metabolism. Clozapine and olanzapine may, in addition to mechanisms resulting from weight gain, impair glucose metabolism by blockade of the muscarinic M3 receptor (M3R). Antidepressants associated with weight gain appear to have fewer unfavourable effects on glucose and lipid metabolism than the second-generation antipsychotics clozapine and olanzapine. To assess the risk of weight gain and its consequences for the patient's health, assessing body weight changes and metabolic monitoring in the first week of treatment as well as in long-term treatment is recommended.

Overview

Integrity signals

Registry

Crossref · 10.2174/1871530315666150623092031

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 89 references

Cited by

See all 123

Metadata

Authors
Himmerich, H., Minkwitz, J., & Kirkby, K.
Affiliations
Leipzig University (DE)
Venue
Endocrine, Metabolic & Immune Disorders-Drug Targets
Published
2015-12-08
Volume
15
Issue
4
Pages
252-260
ISSN
1871-5303 (ISSN-L)
OpenAlex
W2099189795
Cited by
122
References
89
Citations by year
2026: 10 · 2025: 5 · 2024: 12 · 2023: 16 · 2022: 13 · 2021: 12 · 2020: 11 · 2019: 15 · 2018: 11 · 2017: 11 · 2016: 4 · 2015: 2
FWCI
7.61
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Endocrine Metabolic & Immune Disorders - Drug Targets (publishedVersion)
  • PubMed (publishedVersion)
  • eCite Digital Repository (University of Tasmania) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
Keywords
antipsychotic-induced weight gain, antidepressant-induced weight gain, clozapine, olanzapine, tricyclic antidepressants, mirtazapine, metabolic side effects, glucose metabolism, lipid metabolism, AMPK, ghrelin, leptin, adiponectin, TNF-α, neuropeptide Y, melanocortin-4 receptor, 5-HT2C receptor, CB1 receptor, M3 muscarinic receptor, metabolic monitoring
MeSH terms
Animals, Antidepressive Agents, Humans, Hyperlipidemias, Polymorphism, Genetic, Antipsychotic Agents, Weight Gain, Drug Monitoring, Glucose Intolerance, Genetic Predisposition to Disease, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants. https://app.cochat.ai/papers/10.2174/1871530315666150623092031
The paper
Himmerich, H., Minkwitz, J., & Kirkby, K. (2015). Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants. Endocrine, Metabolic & Immune Disorders-Drug Targets. https://doi.org/10.2174/1871530315666150623092031

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.